TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive Funding Opportunities: RFAs For Mouse Models Consortium, Urology Research Centers August 7, 1998
TCL Archive Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI. June 11, 2004